Latest Articles
Toronto researchers use AI to tackle endometriosis diagnostic delays - CTV News
Toronto researchers use AI to tackle endometriosis diagnostic delays CTV News
Published: April 12, 2026, 9 a.m.
Are microplastics affecting your fertility? The silent threat of plastic in the ovaries - theweek.in
Are microplastics affecting your fertility? The silent threat of plastic in the ovaries theweek.in
Published: April 12, 2026, 8:53 a.m.
Woman Creates Wellness Network After Life Challenges Transform Mindset - world.infonasional.com
Woman Creates Wellness Network After Life Challenges Transform Mindset world.infonasional.com
Published: April 12, 2026, 6:15 a.m.
Woman Gets Endometriosis Diagnosis After Years of ‘Debilitating’ Pain, Calls Treatment Options 'Barbaric’ - AOL.com
Woman Gets Endometriosis Diagnosis After Years of ‘Debilitating’ Pain, Calls Treatment Options 'Barbaric’ AOL.com
Published: April 12, 2026, 2:13 a.m.
Trastuzumab Pamirtecan Elicits Responses in HER2-Expressing Advanced/Metastatic Endometrial Cancer - OncLive
Trastuzumab Pamirtecan Elicits Responses in HER2-Expressing Advanced/Metastatic Endometrial Cancer OncLive
Published: April 11, 2026, 6:14 p.m.
BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer - Quiver Quantitative
BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer Quiver Quantitative
Published: April 11, 2026, 11:10 a.m.
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times
Published: April 11, 2026, 11:01 a.m.
In recurrent endometrial cancer, BioNTech drug held off progression 8 months - Stock Titan
In recurrent endometrial cancer, BioNTech drug held off progression 8 months Stock Titan
Published: April 11, 2026, 11 a.m.
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment - BioSpectrum Asia
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment BioSpectrum Asia
Published: April 11, 2026, 7:52 a.m.
MP calls for urgent action on endometriosis diagnosis delays - The Argus
MP calls for urgent action on endometriosis diagnosis delays The Argus
Published: April 11, 2026, 4 a.m.
Link copied to clipboard!